Search results for "Trends"

showing 10 items of 207 documents

Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data

2017

ObjectiveTo validate the estimates of Global Burden of Disease (GBD) due to congenital anomaly for Europe by comparing infant mortality data collected by EUROCAT registries with the WHO Mortality Database, and by assessing the significance of stillbirths and terminations of pregnancy for fetal anomaly (TOPFA) in the interpretation of infant mortality statistics.Design, setting and outcome measuresEUROCAT is a network of congenital anomaly registries collecting data on live births, fetal deaths from 20 weeks’ gestation and TOPFA. Data from 29 registries in 19 countries were analysed for 2005–2009, and infant mortality (deaths of live births at age <1 year) compared with the WHO Mortality …

0301 basic medicineMalePediatrics030105 genetics & heredityInfant DeathGlobal Burden of Disease0302 clinical medicineCongenital anomaly ; DALY ; Global Burden of Disease ; YLL ; mortality.PregnancyPrenatal DiagnosisYLLEpidemiologyInfant MortalityPrevalenceMedicineEPIDEMIOLOGY030212 general & internal medicineRegistries1506DOWN-SYNDROMEPOPULATIONeducation.field_of_studyDALYAnomaly (natural sciences)Pregnancy OutcomeObstetrics and GynecologyGestational ageGeneral MedicineStillbirthUPDATED SYSTEMATIC ANALYSISPREVALENCEEuropeFetal Mortality/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleOriginal ArticleCHILD-MORTALITYAdultCOUNTRIESmedicine.medical_specialtyPopulationGestational AgeCongenital Abnormalities03 medical and health sciencesSDG 3 - Good Health and Well-beingJournal ArticleHumansCongenital anomalyAbortion Induced/statistics & numerical data; Adult; Congenital Abnormalities/diagnosis; Congenital Abnormalities/epidemiology; Europe/epidemiology; Female; Fetal Death/prevention & control; Fetal Mortality; Gestational Age; Global Burden of Disease/methods; Global Burden of Disease/statistics & numerical data; Humans; Infant; Infant Death/prevention & control; Infant Mortality; Infant Newborn; Male; Pregnancy; Pregnancy Outcome/epidemiology; Prenatal Diagnosis/methods; Prenatal Diagnosis/statistics & numerical data; Prevalence; Registries/statistics & numerical data; Stillbirth/epidemiology; Congenital anomaly; DALY; Global Burden of Disease; YLL; mortalityeducationFetal DeathPregnancybusiness.industryInfant NewbornInfantAbortion InducedNATIONAL CAUSESmedicine.diseasemortalityTRENDSInfant mortalityChild mortalityYears of potential life lostPediatrics Perinatology and Child HealthbusinessPRIMARY PREVENTIONDemography
researchProduct

Prevalence of Age-Related Macular Degeneration in Europe

2017

Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/; International audience; [u]Purpose:[/u] Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of European ancestry. Risk profiles and treatment options have changed considerably over the years, which may have affected disease prevalence and outcome. We determined the prevalence of early and late AMD in Europe from 1990 to 2013 using the European Eye Epidemiology (E3) consortium, and made projections for the future. [u]Design:[/u] Meta-analysis of prevalence data. [u]Participants:[/u] A total of 42 080 individuals 40 years of age and older participating in 14 population-based cohor…

0301 basic medicinemedicine.medical_specialtyVisual acuityOPTICAL COHERENCE TOMOGRAPHYMACULOPATHYgenetic structuresPopulationPrevalenceHEART-DISEASEchoroidal neovascularizationSensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]03 medical and health sciencesRotterdam Study0302 clinical medicineAll institutes and research themes of the Radboud University Medical CenterBEAVER DAM EYEEpidemiologygeographic atrophymedicineVISUAL IMPAIRMENT[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrganseducationPOPULATIONeducation.field_of_studyBIRTH COHORTbusiness.industryMacular degenerationmedicine.diseaseTRENDSConfidence intervaleye diseases3. Good healthEuropean Prospective Investigation into Cancer and NutritionOphthalmology030104 developmental biologyAge-related Macular DegenerationENDOTHELIAL GROWTH-FACTORBLINDNESS030221 ophthalmology & optometryOptometryAge-related Macular Degeneration choroidal neovascularization geographic atrophysense organsmedicine.symptombusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct

The Effect of Course Length on Individual Medley Swimming Performance in National and International Athletes

2014

Abstract Effects of course length (25 m versus 50 m) and advances in performance of individual medley swimming were examined for men and women in Swiss national competitions and FINA World Championships during 2000-2011. Linear regression and analysis of variance (ANOVA) were used to analyse 200 m and 400 m race results for 26,081 swims on the Swiss high score list and 382 FINA finalists. Swiss and FINA swimmers of both sexes were, on average, 4.3±3.2% faster on short courses for both race distances. Sex-related differences in swim speed were significantly greater for FINA swimmers competing in short-course events than in long-course events (10.3±0.2% versus 9.7±0.3%, p<0.01), but did no…

11035 Institute of General PracticeOperations researchPhysical TherapyWORLD RECORDSPhysical Therapy Sports Therapy and Rehabilitation610 Medicine & healthSWIMMERSSports Therapy and Rehabilitationsex-related differenceLIMITS2737 Physiology (medical)temporal trendsPhysiology (medical)MedicineNational level3612 Physical Therapy Sports Therapy and Rehabilitationlcsh:Sports medicinepool lengthPHYSIOLOGYbiologyAthletesbusiness.industrySection III – Sports TrainingWOMENMENVELOCITYbiology.organism_classificationSwimming speedDISTANCEswim speed[ SCCO ] Cognitive sciencebusinesslcsh:RC1200-1245Demography
researchProduct

Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy

2020

This analysis compares reported deaths from COVID-19, February 23 to April 4, 2020, and total mortality in Italy from January 12 through April 4 in the years 2015 through 2020.

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINE01 natural sciences03 medical and health sciencesBetacoronavirus0302 clinical medicineCOVID-19 TestingPandemicInternal MedicineResearch LetterMedicineHumans030212 general & internal medicine0101 mathematicsMortalityMortality trendsDisease NotificationPandemicsbusiness.industryClinical Laboratory TechniquesSARS-CoV-2010102 general mathematicsCOVID-19covidPublic Reporting of Healthcare DataTotal mortalityItalyDisease NotificationEmergency medicinebusinessCoronavirus InfectionsCoronavirus Infections
researchProduct

Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine

2019

BackgroundProstate cancer incidence varies internationally largely attributable to differences in prostate-specific antigen (PSA) use. The aim of this study was to provide the most recent detailed international epidemiological comparison of prostate cancer incidence and mortality in six north-eastern European countries (Belarus, Estonia, Latvia, Lithuania, the Russian Federation and Ukraine).MethodsThe number of incident prostate cancer cases was obtained from the countries national cancer registries. Prostate cancer mortality and corresponding population data were extracted from the WHO Mortality Database. Age-specific and age-standardised incidence and mortality rates were calculated (Eur…

AdultBaltic StatesMaletrendsmedicine.medical_specialtyRepublic of BelarusEpidemiology030232 urology & nephrologyPrevalenceRussia03 medical and health sciencesProstate cancer0302 clinical medicineProstateSyöpätaudit - CancersEpidemiologymedicineHumans1506AgedOriginal ResearchAged 80 and overProstate cancerbusiness.industryIncidenceIncidence (epidemiology)Mortality rateProstatic NeoplasmsCancerGeneral MedicineMiddle Agedmedicine.diseasemortality1692Prostate-specific antigenmedicine.anatomical_structure030220 oncology & carcinogenesisincidencePSA uptakeUkrainebusinessDemography
researchProduct

Cancer in children and adolescents in Europe: Developments over 20 years and future challengers

2006

This special issue contains 18 articles describing population-based analyses of incidence and survival for cancer among children and adolescents in Europe over the period 1978-1997. The analyses were derived from the large database of the ACCIS project (Automated Childhood Cancer Information System), which was built through collaboration of 62 population-based cancer registries in 19 European countries. Data on 88,465 cancers in children and 15,369 in adolescents (age 15-19 yrs) were included in the various analyses, making this the largest database on cancer in these age-groups in the world. National data were grouped into five European regions to allow comparisons of incidence and surviva…

AdultCancer ResearchPediatricsmedicine.medical_specialtycancer incidenceTime FactorsAdolescentDatabases FactualPopulationSDG 3 - Good Health and Well-beingNeoplasmsmedicineHumansRegistriesMortalityeducationChildeducation.field_of_studycancer incidence; Childhood cancers - survival - time trendsbusiness.industryPublic healthIncidence (epidemiology)IncidenceConfoundingInfant NewbornCancerInfantmedicine.diseaseSurvival AnalysisEuropeOncologyEl NiñoData qualityChild PreschoolEtiologybusinessChildhood cancers - survival - time trendsDemography
researchProduct

The age-related performance decline in ultraendurance mountain biking

2013

Haupt, Samuel | Knechtle, Beat | Knechtle, Patrizia | Ruest, Christoph Alexander | Rosemann, Thomas | Lepers, Romuald; International audience; ''The age-related changes in ultraendurance performance have been previously examined for running and triathlon but not mountain biking. The aims of this study were (i) to describe the performance trends and (ii) to analyze the age-related performance decline in ultraendurance mountain biking in a 120-km ultraendurance mountain bike race the Swiss Bike Masters from 1995 to 2009 in 9,325 male athletes. The mean (+/- SD) race time decreased from 590 +/- 80 min to 529 +/- 88 min for overall finishers and from 415 +/- 8 min to 359 +/- 16 min for the top …

AdultMale11035 Institute of General PracticeTime FactorsInjury controlAccident preventionPhysical TherapyMountain bikingPoison controlPhysical Therapy Sports Therapy and Rehabilitation610 Medicine & healthSports Therapy and RehabilitationAthletic PerformanceYoung Adult03 medical and health sciencesOFF-ROAD0302 clinical medicine2732 Orthopedics and Sports MedicineAge groupsAge relatedMARATHONHumansMedicineOrthopedics and Sports Medicine''OFF-ROAD3612 Physical Therapy Sports Therapy and RehabilitationAnalysis of VarianceGENDER-DIFFERENCESTRIATHLONTRENDS''business.industry[SCCO.NEUR]Cognitive science/NeuroscienceAge Factors030229 sport sciencesMiddle AgedTRENDSBicycling[ SCCO.NEUR ] Cognitive science/NeurosciencePhysical EnduranceFemalebusiness030217 neurology & neurosurgeryDemographyOff road cycling
researchProduct

Time trends and short term projections of cancer prevalence in France

2018

IF 2.888 (2017); International audience; BackgroundThis study analyzes time trends in cancer prevalence in France and provides short-term projections up to the year 2017. The 15-year prevalence for 24 cancers was estimated from the French cancer registries network (FRANCIM) incidence and survival data.MethodWe estimated prevalence using the P = I × S relationship, with flexible modeling of incidence and survival. Based on observations of the incidence and survival up to 2010, different scenarios for evolution up to 2017 were studied, combining stable and dynamic incidence and survival. The determinants of variations in prevalence (incidence, survival and demography) were quantified.ResultsA…

AdultMaleCancer ResearchTime FactorsAdolescentEpidemiologyPopulation[SDV.CAN]Life Sciences [q-bio]/Cancer030501 epidemiologyProjection scenariosYoung Adult03 medical and health sciences0302 clinical medicineSurvival dataNeoplasmsPrevalencemedicineHumansRegistrieseducationCancer prevalenceAgedAged 80 and overeducation.field_of_studybusiness.industryTime trendsIncidenceIncidence (epidemiology)CancerTime trendsMiddle AgedPrognosismedicine.diseaseShort-term projections3. Good healthSurvival RateOncologyDemographic change030220 oncology & carcinogenesisFemaleFranceFlexible models0305 other medical sciencebusinessDemographyCancer Epidemiology
researchProduct

Estimation de l’incidence des hémopathies malignes en France entre 1980 et 2012

2016

International audience; BACKGROUND:The classification of hematological malignancies (HMs) has changed in recent decades. For the first time, the French network of cancer registries (Francim) provides estimates for incidence and trends of HM in France between 1980 and 2012 for major HM subtypes.METHODS:Incidence was directly estimated by modeling the incidence rates measured in the cancer registry area. For each HM subtype, a "usable incidence period" was defined a priori, corresponding to the years for which all the registries collected them in a homogeneous way. For both sexes and each HM subtype, age-period-cohort models were used to estimate national incidence trends.RESULTS:Overall in F…

AdultMaleOncologyPediatricsmedicine.medical_specialtyRegistryAdolescentEpidemiologyChronic lymphocytic leukemiaFollicular lymphoma[SDV.CAN]Life Sciences [q-bio]/Cancer[ SDV.CAN ] Life Sciences [q-bio]/CancerHematological malignanciesYoung Adult03 medical and health sciences0302 clinical medicineNeoplasmsInternal medicinemedicineHumansRegistriesAgedAged 80 and overbusiness.industryMyelodysplastic syndromesIncidence (epidemiology)IncidencePublic Health Environmental and Occupational HealthCancer[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieHémopathies malignesMiddle AgedPlasma cell neoplasmmedicine.disease3. Good healthLymphomaCancer registryTendancesHematologic Neoplasms030220 oncology & carcinogenesisFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFranceTrendsbusinessRegistre de population030215 immunology
researchProduct

Trends and Prevalence of Nocturia Among US Adults, 2005-2016

2019

Purpose: Increased nocturia episodes can be a clinical marker of poor health status. The present study aimed to evaluate patterns and temporal trends in nocturia and sociodemographic and lifestyle correlates in the US population. Methods: Participants, aged 20 years or older, were included in this repeated cross-sectional study. The National Health and Nutrition Examination Survey from 2005 to 2016 was used. Participants were asked “During the past 30 days, how many times per night did you most typically get up to urinate, from the time you went to bed at night until the time you got up in the morning?”. Individuals were categorized as either ≥ 1 nocturia episode or ≥ 2 nocturia episodes pe…

AdultMaleTime FactorsNational Health and Nutrition Examination SurveyUrologymedia_common.quotation_subjectPopulation030232 urology & nephrologyClinical marker030204 cardiovascular system & hematologyUrination03 medical and health sciencesYoung AdultSoysal P. Cao C. Xu T. Yang L. Isik A. Turan K. Liu Q. Pizzol D. Veronese N. Demurtas J. et al. -Trends and prevalence of nocturia among US adults 2005-2016.- International urology and nephrology 20190302 clinical medicineAge groupsPrevalenceMedicineNocturiaHumanseducationNocturia · Trend · United States · NHANESMorningmedia_commoneducation.field_of_studybusiness.industryMiddle AgedUnited StatesSecular variationCross-Sectional StudiesNephrologyFemaleNocturiamedicine.symptombusinessDemography
researchProduct